文献速递肝病

病因治愈可预防以腹水为单一首次失代偿事件的肝硬化患者进一步失代偿和死亡

Etiological cure prevents further decompensation and mortality in patients with cirrhosis with ascites as the single first decompensating event.
PubMed 文献 · Hepatology · 2023-05-17

研究纳入622例以腹水为单一首次失代偿事件的肝硬化患者,按病因状态分为治愈、控制和未控制三组。多变量分析显示,病因治愈与进一步失代偿风险降低(HR 0.46,p=0.001)和死亡风险降低(HR 0.35,p<0.001)独立相关。结论认为病因治愈是主要治疗目标。

要点

  • 病因治愈与进一步失代偿风险降低独立相关(HR 0.46,p=0.001)。
  • 病因治愈与死亡风险降低独立相关(HR 0.35,p<0.001)。
  • 以腹水为单一首次失代偿事件的肝硬化患者中,病因治愈是主要治疗目标。

核心结论

  • 在肝硬化以腹水为单一首次失代偿事件的患者中,病因治愈是主要治疗目标,可显著降低进一步失代偿和死亡风险。

研究设计与样本

  • 纳入以腹水为单一首次失代偿事件的肝硬化患者,随访至死亡、肝移植或2021年第三季度。
  • 共纳入622例患者,病因状态分为治愈(戒酒、丙型肝炎治愈、乙型肝炎抑制)、控制(部分去除病因)和未控制。

主要发现

  • 病因治愈146例(24%),控制170例(27%),未控制306例(49%)。
  • 随访期间350例(56%)发生进一步失代偿。
  • 多变量分析(校正年龄、性别、静脉曲张、病因、Child-Pugh分级、肌酐、钠和失代偿年代)显示,病因治愈与进一步失代偿风险降低独立相关(HR 0.46,p=0.001)。
  • 随访期间250例(40.2%)死亡,104例(16.7%)接受肝移植。
  • 多变量分析显示,病因治愈与死亡风险降低独立相关(HR 0.35,p<0.001)。

临床怎么用

  • 原文结论认为,在肝硬化以腹水为单一首次失代偿事件的患者中,病因治愈是主要治疗目标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Removal/suppression of the primary etiological factor reduces the risk of decompensation and mortality in compensated cirrhosis. However, in decompensated cirrhosis, the impact of etiologic treatment is less predictable. We aimed to evaluate the impact of etiological treatment in patients with cirrhosis who developed ascites as single index decompensating event. APPROACH AND RESULTS: Patients with cirrhosis and ascites as single first decompensation event were included and followed until death, liver transplantation, or Q3/2021. The etiology was considered "cured" (alcohol abstinence, hepatitis C cure, and hepatitis B suppression) versus "controlled" (partial removal of etiologic factors) versus "uncontrolled." A total of 622 patients were included in the study. Etiology was "cured" in 146 patients (24%), "controlled" in 170 (27%), and "uncontrolled" in 306 (49%). During follow-up, 350 patients (56%) developed further decompensation. In multivariable analysis (adjusted for age, sex, varices, etiology, Child-Pugh class, creatinine, sodium, and era of decompensation), etiological cure was independently associated with a lower risk of further decompensation (HR: 0.46; p = 0.001). During follow-up, 250 patients (40.2%) died, while 104 (16.7%) underwent LT. In multivariable analysis, etiological cure was independently associated with a lower mortality risk (HR: 0.35, p < 0.001). CONCLUSIONS: In patients with cirrhosis and ascites as single first decompensating event, the cure of liver disease etiology represents a main treatment goal since this translates into considerably lower risks of further decompensation and mortality.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Tonon M, Balcar L, Semmler G, et al. Etiological cure prevents further decompensation and mortality in patients with cirrhosis with ascites as the single first decompensating event. Hepatology. 2023. PMID: 37190823. doi:10.1097/HEP.0000000000000460

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。